Bottcher L, Fonseca L, Laubenbacher R
Philos Trans A Math Phys Eng Sci. 2025; 383(2292):20240228.
PMID: 40078154
PMC: 11904622.
DOI: 10.1098/rsta.2024.0228.
Colegrove H, Monnat R, Monnat Jr R, Feder A
bioRxiv. 2025; .
PMID: 40060430
PMC: 11888451.
DOI: 10.1101/2025.02.26.640284.
Kaity B, Lobo D
bioRxiv. 2025; .
PMID: 40027769
PMC: 11870555.
DOI: 10.1101/2025.02.16.638504.
Fonseca L, Bottcher L, Mehrad B, Laubenbacher R
PLoS Comput Biol. 2025; 21(1):e1012138.
PMID: 39808665
PMC: 11790234.
DOI: 10.1371/journal.pcbi.1012138.
Qayyum M, Ahmad E, Ali M
Heliyon. 2024; 10(14):e34160.
PMID: 39669766
PMC: 11637049.
DOI: 10.1016/j.heliyon.2024.e34160.
Personalizing computational models to construct medical digital twins.
Knapp A, Cruz D, Mehrad B, Laubenbacher R
bioRxiv. 2024; .
PMID: 39574674
PMC: 11580862.
DOI: 10.1101/2024.05.31.596692.
Towards verifiable cancer digital twins: tissue level modeling protocol for precision medicine.
Kemkar S, Tao M, Ghosh A, Stamatakos G, Graf N, Poorey K
Front Physiol. 2024; 15:1473125.
PMID: 39507514
PMC: 11537925.
DOI: 10.3389/fphys.2024.1473125.
SMoRe GloS: An efficient and flexible framework for inferring global sensitivity of agent-based model parameters.
Bergman D, Jackson T, Jain H, Norton K
bioRxiv. 2024; .
PMID: 39345435
PMC: 11429786.
DOI: 10.1101/2024.09.18.613723.
Modeling tumors as complex ecosystems.
Aguade-Gorgorio G, Anderson A, Sole R
iScience. 2024; 27(9):110699.
PMID: 39280631
PMC: 11402243.
DOI: 10.1016/j.isci.2024.110699.
Mechanistic modeling of cell viability assays with lineage tracing.
Mutsuddy A, Huggins J, Amrit A, Erdem C, Calhoun J, Birtwistle M
bioRxiv. 2024; .
PMID: 39253474
PMC: 11383287.
DOI: 10.1101/2024.08.23.609433.
Integrating mechanism-based T cell phenotypes into a model of tumor-immune cell interactions.
Tangella N, Cess C, Ildefonso G, Finley S
APL Bioeng. 2024; 8(3):036111.
PMID: 39175956
PMC: 11341129.
DOI: 10.1063/5.0205996.
Use of Individual-Based Mathematical Modelling to Understand More About Antibiotic Resistance Within-Host.
Saula A, Rowlatt C, Bowness R
Methods Mol Biol. 2024; 2833:93-108.
PMID: 38949704
DOI: 10.1007/978-1-0716-3981-8_10.
Pediatric Leukemia Roadmaps Are a Guide for Positive Metastatic Bone Sarcoma Trials.
Reed D, Tulpule A, Metts J, Trucco M, Robertson-Tessi M, ODonohue T
J Clin Oncol. 2024; 42(25):2955-2960.
PMID: 38843482
PMC: 11534082.
DOI: 10.1200/JCO.23.02717.
Surrogate modeling and control of medical digital twins.
Fonseca L, Bottcher L, Mehrad B, Laubenbacher R
ArXiv. 2024; .
PMID: 38827450
PMC: 11142319.
Modeling tumors as species-rich ecological communities.
Aguade-Gorgorio G, Anderson A, Sole R
bioRxiv. 2024; .
PMID: 38712062
PMC: 11071393.
DOI: 10.1101/2024.04.22.590504.
Agent-based modeling in cancer biomedicine: applications and tools for calibration and validation.
Cogno N, Axenie C, Bauer R, Vavourakis V
Cancer Biol Ther. 2024; 25(1):2344600.
PMID: 38678381
PMC: 11057625.
DOI: 10.1080/15384047.2024.2344600.
Bridging systems biology and tissue engineering: Unleashing the full potential of complex 3D tissue models of disease.
Cadavid J, Li N, McGuigan A
Biophys Rev (Melville). 2024; 5(2):021301.
PMID: 38617201
PMC: 11008916.
DOI: 10.1063/5.0179125.
Incorporating temporal information during feature engineering bolsters emulation of spatio-temporal emergence.
Cain J, Evarts J, Yu J, Bagheri N
Bioinformatics. 2024; 40(3).
PMID: 38444088
PMC: 10957516.
DOI: 10.1093/bioinformatics/btae131.
Tumor-immune metaphenotypes orchestrate an evolutionary bottleneck that promotes metabolic transformation.
West J, Rentzeperis F, Adam C, Bravo R, Luddy K, Robertson-Tessi M
Front Immunol. 2024; 15:1323319.
PMID: 38426105
PMC: 10902449.
DOI: 10.3389/fimmu.2024.1323319.
Agent-based modeling of the prostate tumor microenvironment uncovers spatial tumor growth constraints and immunomodulatory properties.
van Genderen M, Kneppers J, Zaalberg A, Bekers E, Bergman A, Zwart W
NPJ Syst Biol Appl. 2024; 10(1):20.
PMID: 38383542
PMC: 10881528.
DOI: 10.1038/s41540-024-00344-6.